UCB SA Revenue vs. Price To Earning
| UCBJF Stock | USD 174.00 0.00 0.00% |
For UCB SA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of UCB SA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well UCB SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between UCB SA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of UCB SA over time as well as its relative position and ranking within its peers.
UCB |
UCB SA Price To Earning vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining UCB SA's current stock value. Our valuation model uses many indicators to compare UCB SA value to that of its competitors to determine the firm's financial worth. UCB SA is rated first in revenue category among its peers. It is rated first in price to earning category among its peers . The ratio of Revenue to Price To Earning for UCB SA is about 327,866,061 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the UCB SA's earnings, one of the primary drivers of an investment's value.UCB Revenue vs. Competition
UCB SA is rated first in revenue category among its peers. Market size based on revenue of Biotechnology industry is at this time estimated at about 232.03 Billion. UCB SA holds roughly 5.78 Billion in revenue claiming about 2.49% of stocks in Biotechnology industry.
UCB Price To Earning vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
UCB SA |
| = | 5.78 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
UCB SA |
| = | 17.62 X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
UCB Price To Earning Comparison
UCB SA is currently under evaluation in price to earning category among its peers.
UCB SA Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in UCB SA, profitability is also one of the essential criteria for including it into their portfolios because, without profit, UCB SA will eventually generate negative long term returns. The profitability progress is the general direction of UCB SA's change in net profit over the period of time. It can combine multiple indicators of UCB SA, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company was incorporated in 1925 and is headquartered in Brussels, Belgium. Ucb SA operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8600 people.
UCB Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on UCB SA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of UCB SA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the UCB SA's important profitability drivers and their relationship over time.
Use UCB SA in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if UCB SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UCB SA will appreciate offsetting losses from the drop in the long position's value.UCB SA Pair Trading
UCB SA Pair Trading Analysis
The ability to find closely correlated positions to UCB SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace UCB SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back UCB SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling UCB SA to buy it.
The correlation of UCB SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as UCB SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if UCB SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for UCB SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your UCB SA position
In addition to having UCB SA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Equity ETFs Thematic Idea Now
Broad Equity ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Equity ETFs theme has 483 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Equity ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in UCB Pink Sheet
To fully project UCB SA's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of UCB SA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include UCB SA's income statement, its balance sheet, and the statement of cash flows.